TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells
- 4 June 2008
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 22 (7) , 1032-1040
- https://doi.org/10.1016/j.bbi.2008.04.005
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activityMolecular Immunology, 2006
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide promote in vivo generation of memory Th2 cellsThe FASEB Journal, 2002
- Regulation of T Cell Receptor CD3ζ Chain Expression byl-ArginineJournal of Biological Chemistry, 2002
- TH2 Lymphocytes Secrete Functional VIP upon Antigen StimulationArchives of Physiology and Biochemistry, 2001
- Down-regulation of Cytokine Expression in Murine Lymphocytes by PACAP and VIPAnnals of the New York Academy of Sciences, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptorMolecular and Cellular Endocrinology, 1995
- Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complexJournal of Neuroimmunology, 1993
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970